The pain management devices and therapies market size has grown strongly in recent years. It will grow from $5.34 billion in 2025 to $5.75 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rising chronic pain prevalence, increased cancer pain cases, opioid-related risks, growth in neurology treatments, hospital adoption of stimulators.
The pain management devices and therapies market size is expected to see strong growth in the next few years. It will grow to $7.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to aging population growth, technological advances in neurostimulators, demand for long-term pain relief, expansion of outpatient pain clinics, increasing healthcare expenditure. Major trends in the forecast period include growing adoption of neurostimulation therapies, rising use of non-opioid pain management, expansion of implantable pain devices, increasing demand for chronic pain treatments, shift toward minimally invasive pain procedures.
The rising prevalence of chronic pain conditions is increasingly supporting the expansion of the pain management devices and therapies market going forward. Chronic pain conditions involve persistent or recurring pain lasting three months or longer and often interfere with daily activities and overall quality of life. The growing prevalence of chronic pain is closely linked to aging populations, as older adults are more vulnerable to degenerative joint diseases and long-term health conditions that cause continuous discomfort. Pain management devices and therapies provide targeted, non-invasive relief suitable for long-term use, offering consistent and personalized pain control that improves patient comfort and quality of life. For example, in November 2024, according to the National Center for Health Statistics, a US-based federal agency, approximately 24.3% of adults in the United States experienced chronic pain in 2023. As a result, the increasing prevalence of chronic pain conditions is reinforcing growth in the pain management devices and therapies market.
Leading companies operating in the pain management devices and therapies market are developing advanced neuromodulation technologies, such as closed-loop spinal cord stimulation systems, to deliver personalized pain relief and improve therapy effectiveness. Closed-loop spinal cord stimulation systems continuously monitor neural responses and automatically adjust stimulation in real time to maintain consistent pain relief. For example, in April 2024, Medtronic plc received FDA approval for its Inceptiv closed-loop rechargeable spinal cord stimulator for chronic pain treatment. The fully implantable device uses proprietary sensing technology to capture biological signals and deliver data-driven therapy with automatic real-time adjustment, reducing the need for patient intervention.
In April 2025, Globus Medical Inc., a US-based musculoskeletal technology company, acquired Nevro Corp. for an undisclosed amount. With this acquisition, Globus Medical aims to accelerate market adoption of Nevro’s differentiated high-frequency technology and broaden treatment options for patients suffering from chronic pain. Nevro Corp. is a US-based medical device company specializing in high-frequency spinal cord stimulation systems for chronic pain management.
Major companies operating in the pain management devices and therapies market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Baxter International Inc., Johnson & Johnson, Smiths Medical Inc., Becton Dickinson and Company, DJO Global Inc., B Braun Melsungen AG, Neurotech Na, Nevro Corp, NeuroMetrix Inc, Medovex Corporation, Halyard Health Inc, Flowonix Medical Inc, Pain Management Technologies Inc, Avanos Medical Inc, Stimwave Technologies LLC, Omron Healthcare Inc., Stryker Corporation, ICU Medical Inc., Nipro Corporation, Zynex Medical Inc., Saluda Medical Pty Ltd., SPR Therapeutics.
North America was the largest region in the pain management devices and therapies market in 2025. Western Europe was the second-largest region in the pain management devices and therapies market report. The regions covered in the pain management devices and therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pain management devices and therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pain management devices market by increasing costs of electronic components, implantable device materials, and precision sensors, particularly affecting neurostimulation and infusion pump segments. North America and Asia-Pacific supply chains are most exposed. Positively, tariffs are encouraging domestic manufacturing and innovation in modular, cost-efficient pain management solutions.
The pain management devices and therapies market research report is one of a series of new reports that provides pain management devices and therapies market statistics, including pain management devices and therapies industry global market size, regional shares, competitors with a pain management devices and therapies market share, detailed pain management devices and therapies market segments, market trends and opportunities, and any further data you may need to thrive in the pain management devices and therapies industry. This pain management devices and therapies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pain management devices and therapies are used to control chronic and severe pain in patients suffering from various medical conditions, including cancer and neurological disorders. They are primarily used for procedures such as spinal cord stimulation, sacral nerve stimulation, and deep brain stimulation.
The main categories in the pain management devices and therapies market include electrical stimulators, ablation devices, neurostimulators, and analgesic infusion pumps. Electrical stimulation devices include transcutaneous electrical nerve stimulation (TENS) devices, neuromuscular electrical stimulation (NMES/EMS) devices, combination therapy units, electrotherapy devices, and TNS systems, while ablation devices include radiofrequency ablation and cryoablation technologies, and neurostimulation devices include spinal cord stimulation (SCS), deep brain stimulation, vagus nerve stimulation, and sacral nerve stimulation systems. Analgesic infusion pumps include intrathecal and external pumps used for managing neuropathic pain, cancer-related pain, facial and migraine pain, musculoskeletal pain, and trauma-related pain.
The pain management devices and therapies market consist of sales of physical therapy, massage, acupuncture, osteopathic manipulative treatment (OMT) and chiropractic adjustments. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pain management devices and therapies market size is expected to see strong growth in the next few years. It will grow to $7.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to aging population growth, technological advances in neurostimulators, demand for long-term pain relief, expansion of outpatient pain clinics, increasing healthcare expenditure. Major trends in the forecast period include growing adoption of neurostimulation therapies, rising use of non-opioid pain management, expansion of implantable pain devices, increasing demand for chronic pain treatments, shift toward minimally invasive pain procedures.
The rising prevalence of chronic pain conditions is increasingly supporting the expansion of the pain management devices and therapies market going forward. Chronic pain conditions involve persistent or recurring pain lasting three months or longer and often interfere with daily activities and overall quality of life. The growing prevalence of chronic pain is closely linked to aging populations, as older adults are more vulnerable to degenerative joint diseases and long-term health conditions that cause continuous discomfort. Pain management devices and therapies provide targeted, non-invasive relief suitable for long-term use, offering consistent and personalized pain control that improves patient comfort and quality of life. For example, in November 2024, according to the National Center for Health Statistics, a US-based federal agency, approximately 24.3% of adults in the United States experienced chronic pain in 2023. As a result, the increasing prevalence of chronic pain conditions is reinforcing growth in the pain management devices and therapies market.
Leading companies operating in the pain management devices and therapies market are developing advanced neuromodulation technologies, such as closed-loop spinal cord stimulation systems, to deliver personalized pain relief and improve therapy effectiveness. Closed-loop spinal cord stimulation systems continuously monitor neural responses and automatically adjust stimulation in real time to maintain consistent pain relief. For example, in April 2024, Medtronic plc received FDA approval for its Inceptiv closed-loop rechargeable spinal cord stimulator for chronic pain treatment. The fully implantable device uses proprietary sensing technology to capture biological signals and deliver data-driven therapy with automatic real-time adjustment, reducing the need for patient intervention.
In April 2025, Globus Medical Inc., a US-based musculoskeletal technology company, acquired Nevro Corp. for an undisclosed amount. With this acquisition, Globus Medical aims to accelerate market adoption of Nevro’s differentiated high-frequency technology and broaden treatment options for patients suffering from chronic pain. Nevro Corp. is a US-based medical device company specializing in high-frequency spinal cord stimulation systems for chronic pain management.
Major companies operating in the pain management devices and therapies market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Baxter International Inc., Johnson & Johnson, Smiths Medical Inc., Becton Dickinson and Company, DJO Global Inc., B Braun Melsungen AG, Neurotech Na, Nevro Corp, NeuroMetrix Inc, Medovex Corporation, Halyard Health Inc, Flowonix Medical Inc, Pain Management Technologies Inc, Avanos Medical Inc, Stimwave Technologies LLC, Omron Healthcare Inc., Stryker Corporation, ICU Medical Inc., Nipro Corporation, Zynex Medical Inc., Saluda Medical Pty Ltd., SPR Therapeutics.
North America was the largest region in the pain management devices and therapies market in 2025. Western Europe was the second-largest region in the pain management devices and therapies market report. The regions covered in the pain management devices and therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pain management devices and therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pain management devices market by increasing costs of electronic components, implantable device materials, and precision sensors, particularly affecting neurostimulation and infusion pump segments. North America and Asia-Pacific supply chains are most exposed. Positively, tariffs are encouraging domestic manufacturing and innovation in modular, cost-efficient pain management solutions.
The pain management devices and therapies market research report is one of a series of new reports that provides pain management devices and therapies market statistics, including pain management devices and therapies industry global market size, regional shares, competitors with a pain management devices and therapies market share, detailed pain management devices and therapies market segments, market trends and opportunities, and any further data you may need to thrive in the pain management devices and therapies industry. This pain management devices and therapies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pain management devices and therapies are used to control chronic and severe pain in patients suffering from various medical conditions, including cancer and neurological disorders. They are primarily used for procedures such as spinal cord stimulation, sacral nerve stimulation, and deep brain stimulation.
The main categories in the pain management devices and therapies market include electrical stimulators, ablation devices, neurostimulators, and analgesic infusion pumps. Electrical stimulation devices include transcutaneous electrical nerve stimulation (TENS) devices, neuromuscular electrical stimulation (NMES/EMS) devices, combination therapy units, electrotherapy devices, and TNS systems, while ablation devices include radiofrequency ablation and cryoablation technologies, and neurostimulation devices include spinal cord stimulation (SCS), deep brain stimulation, vagus nerve stimulation, and sacral nerve stimulation systems. Analgesic infusion pumps include intrathecal and external pumps used for managing neuropathic pain, cancer-related pain, facial and migraine pain, musculoskeletal pain, and trauma-related pain.
The pain management devices and therapies market consist of sales of physical therapy, massage, acupuncture, osteopathic manipulative treatment (OMT) and chiropractic adjustments. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pain Management Devices and Therapies Market Characteristics
3. Pain Management Devices and Therapies Market Supply Chain Analysis
4. Global Pain Management Devices and Therapies Market Trends and Strategies
5. Pain Management Devices and Therapies Market Analysis of End Use Industries
7. Global Pain Management Devices and Therapies Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pain Management Devices and Therapies Total Addressable Market (TAM) Analysis for the Market
9. Pain Management Devices and Therapies Market Segmentation
10. Pain Management Devices and Therapies Market Regional and Country Analysis
11. Asia-Pacific Pain Management Devices and Therapies Market
12. China Pain Management Devices and Therapies Market
13. India Pain Management Devices and Therapies Market
14. Japan Pain Management Devices and Therapies Market
15. Australia Pain Management Devices and Therapies Market
16. Indonesia Pain Management Devices and Therapies Market
17. South Korea Pain Management Devices and Therapies Market
18. Taiwan Pain Management Devices and Therapies Market
19. South East Asia Pain Management Devices and Therapies Market
20. Western Europe Pain Management Devices and Therapies Market
21. UK Pain Management Devices and Therapies Market
22. Germany Pain Management Devices and Therapies Market
23. France Pain Management Devices and Therapies Market
24. Italy Pain Management Devices and Therapies Market
25. Spain Pain Management Devices and Therapies Market
26. Eastern Europe Pain Management Devices and Therapies Market
27. Russia Pain Management Devices and Therapies Market
28. North America Pain Management Devices and Therapies Market
29. USA Pain Management Devices and Therapies Market
30. Canada Pain Management Devices and Therapies Market
31. South America Pain Management Devices and Therapies Market
32. Brazil Pain Management Devices and Therapies Market
33. Middle East Pain Management Devices and Therapies Market
34. Africa Pain Management Devices and Therapies Market
36. Pain Management Devices and Therapies Market Competitive Landscape and Company Profiles
37. Pain Management Devices and Therapies Market Other Major and Innovative Companies
40. Pain Management Devices and Therapies Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pain Management Devices And Therapies Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pain management devices and therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pain management devices and therapies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pain management devices and therapies market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Electrical Stimulation Devices; Thermal Therapy Devices; Minimally Invasive Devices; Injection And Infusion Systems; Ultrasound And Laser Therapy Devices; Other Product Types2) By Therapy Type: Pharmacologic Therapies; Non-Pharmacologic Therapies; Interventional Or Surgical Therapies
3) By Pain Indication: Chronic Pain; Acute Pain; Other Pain Conditions
4) By End User: Hospitals; Ambulatory Surgical Centers; Pain Clinics; Rehabilitation Centers; Home Healthcare; Specialty Clinics Or Outpatient Facilities
Subsegments:
1) By Electrical Stimulation Devices: Spinal Cord Stimulators (Scs); Transcutaneous Electrical Nerve Stimulation (Tens); Interferential Current Therapy Devices; Peripheral Nerve Stimulators (Pns); Deep Brain Stimulation (Dbs)2) By Thermal Therapy Devices: Cryotherapy Units; Heat Therapy Pads And Wraps
3) By Minimally Invasive Devices: Radiofrequency Ablation Devices; Epidural Catheters; Intrathecal Drug Delivery Systems; Neuroablative Devices
4) By Injection And Infusion Systems: Pain Infusion Pumps; Needle-Based Injectors
5) By Ultrasound And Laser Therapy Devices: Therapeutic Ultrasound; Low-Level Laser Therapy (Lllt)
6) By Other Product Types: Acupuncture Stimulators; Biofeedback And Rehabilitation Devices
Companies Mentioned: Abbott Laboratories; Boston Scientific Corporation; Medtronic plc; Baxter International Inc.; Johnson & Johnson; Smiths Medical Inc.; Becton Dickinson and Company; DJO Global Inc.; B Braun Melsungen AG; Neurotech Na; Nevro Corp; NeuroMetrix Inc; Medovex Corporation; Halyard Health Inc; Flowonix Medical Inc; Pain Management Technologies Inc; Avanos Medical Inc; Stimwave Technologies LLC; Omron Healthcare Inc.; Stryker Corporation; ICU Medical Inc.; Nipro Corporation; Zynex Medical Inc.; Saluda Medical Pty Ltd.; SPR Therapeutics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pain Management Devices and Therapies market report include:- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- Baxter International Inc.
- Johnson & Johnson
- Smiths Medical Inc.
- Becton Dickinson and Company
- DJO Global Inc.
- B Braun Melsungen AG
- Neurotech Na
- Nevro Corp
- NeuroMetrix Inc
- Medovex Corporation
- Halyard Health Inc
- Flowonix Medical Inc
- Pain Management Technologies Inc
- Avanos Medical Inc
- Stimwave Technologies LLC
- Omron Healthcare Inc.
- Stryker Corporation
- ICU Medical Inc.
- Nipro Corporation
- Zynex Medical Inc.
- Saluda Medical Pty Ltd.
- SPR Therapeutics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.75 Billion |
| Forecasted Market Value ( USD | $ 7.38 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
